LEI NIE to Cell- and Tissue-Based Therapy
This is a "connection" page, showing publications LEI NIE has written about Cell- and Tissue-Based Therapy.
Connection Strength
0.044
-
Pirtobrutinib and venetoclax combination overcomes resistance to targeted and chimeric antigen receptor T-cell therapy in aggressive mantle cell lymphoma. Haematologica. 2023 05 01; 108(5):1412-1416.
Score: 0.044